Literature DB >> 12376608

Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings.

Eun A Kim1, Kyung Soo Lee, Takeshi Johkoh, Tae Sung Kim, Gee Young Suh, O Jung Kwon, Joungho Han.   

Abstract

Collagen vascular diseases that demonstrate features of interstitial lung disease include systemic lupus erythematosus, rheumatoid arthritis, progressive systemic sclerosis, dermatomyositis and polymyositis, ankylosing spondylitis, Sjögren syndrome, and mixed connective tissue disease. At histopathologic analysis, interstitial lung diseases associated with collagen vascular diseases are diverse and include nonspecific interstitial pneumonia, usual interstitial pneumonia, bronchiolitis obliterans organizing pneumonia (BOOP), apical fibrosis, diffuse alveolar damage, and lymphocytic interstitial pneumonia. Although proportions of interstitial pneumonias vary, nonspecific interstitial pneumonia accounts for a large proportion, especially in progressive systemic sclerosis, dermatomyositis and polymyositis, and mixed connective tissue disease. The more favorable prognosis in interstitial pneumonia associated with collagen vascular diseases than in idiopathic interstitial pneumonias may be explained by the larger proportion of nonspecific interstitial pneumonia than of usual interstitial pneumonia. High-resolution computed tomography seems to help characterize and determine the extent of interstitial lung disease in collagen vascular diseases.

Entities:  

Mesh:

Year:  2002        PMID: 12376608     DOI: 10.1148/radiographics.22.suppl_1.g02oc04s151

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  29 in total

Review 1.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

2.  Shrinking lung syndrome complicating pediatric systemic lupus erythematosus.

Authors:  Natalie S Burns; Anne M Stevens; Ramesh S Iyer
Journal:  Pediatr Radiol       Date:  2014-04-23

Review 3.  Pulmonary function testing in idiopathic interstitial pneumonias.

Authors:  Fernando J Martinez; Kevin Flaherty
Journal:  Proc Am Thorac Soc       Date:  2006-06

4.  Case 238: Spontaneous Pneumothorax Secondary to Intrapulmonary Necrobiotic Rheumatoid Nodule.

Authors:  Ammar A Chaudhry; Maryam Gul; Abbas A Chaudhry; William Moore
Journal:  Radiology       Date:  2017-02       Impact factor: 11.105

5.  Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.

Authors:  Suparaporn Wangkaew; Juntima Euathrongchit; Pittaporn Wattanawittawas; Nuntana Kasitanon
Journal:  Quant Imaging Med Surg       Date:  2016-08

6.  High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data.

Authors:  Sophie Grivaud Martin; Louis-Philippe Kronek; Dominique Valeyre; Nadia Brauner; Pierre-Yves Brillet; Hilario Nunes; Michel W Brauner; Frédérique Réty
Journal:  Eur Radiol       Date:  2009-12-08       Impact factor: 5.315

7.  Rheumatoid interstitial lung disease presenting as cor pulmonale.

Authors:  Sourya Acharya; S N Mahajan; Samarth Shukla; S K Diwan; Pankaj Banode; Nirmesh Kothari
Journal:  Lung India       Date:  2010-10

Review 8.  Mixed connective tissue disease with interstitial pneumonia in HTLV-1 carrier: case report and review of the literature.

Authors:  Yasuhiro Shimojima; Wataru Ishii; Akiyo Hineno; Kanji Yamamoto; Masayuki Matsuda; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

9.  Lung scintigraphy with nonspecific human immunoglobulin G ((99m)Tc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT).

Authors:  Ch Kostopoulos; J Koutsikos; C Toubanakis; L A Moulopoulos; Ch Mamoulakis; E Gialafos; P P Sfikakis; Ch Zerva; M Mavrikakis; A Leondi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236

Review 10.  Personalized medicine: applying 'omics' to lung fibrosis.

Authors:  Jose D Herazo-Maya; Naftali Kaminski
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.